Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 2Endocrine 2

Conditions

Neuroendocrine Tumors 35Pheochromocytoma 14Pituitary Neoplasms 12Thyroid Neoplasms 11Carcinoma, Neuroendocrine 11Adrenocortical Carcinoma 10Thyroid Cancer, Papillary 9Sarcoma 8Paraganglioma 8Adrenal Gland Neoplasms 7Small Cell Lung Carcinoma 6Neuroblastoma 6Cushing Syndrome 6Parathyroid Neoplasms 5Ovarian Neoplasms 5Neoplasms 5Carcinoma, Medullary 5Carcinoid Tumor 5Pancreatic Neoplasms 4Osteosarcoma 4Multiple Endocrine Neoplasia Type 1 4Meningioma 4Insulinoma 4Cholangiocarcinoma 4Carcinoma, Renal Cell 4Carcinoma, Non-Small-Cell Lung 4Carcinoma, Hepatocellular 4Adenoma, Islet Cell 4Adenocarcinoma, Follicular 4Thyroid Carcinoma, Anaplastic 3

Interventions

gallium Ga 68 dotatate 1Sodium Iodide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Thyroid cancer, Hurthle cell × Endocrine × 30 days × Clear all
NCT00001160 2026-05-12

Studies on Tumors of the Thyroid

National Institutes of Health Clinical Center (CC)

Recruiting
2,500 enrolled
EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT01398085 2026-05-07

IoN

University College, London

Phase 2/3 Active not recruiting
504 enrolled
EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡